史玉卿;
SHI Yuqing;Department of Pathology,Langfang People 's Hospital;

• 1:廊坊市人民医院病理科

摘要(Abstract)：

目的:探讨胸水人乳头瘤病毒16型(HPV16)、缺氧诱导因子1α(HIF1α)及血管内皮生长因子(VEGF)检测对小细胞肺癌的诊断价值。方法:选取79例小细胞肺癌伴胸水患者作为观察组、同期68例良性胸水患者为对照组,应用酶联免疫吸附法检测两组患者胸水中HPV16、HIF1α及VEGF水平,分析3项指标单独检测或联合检测在小细胞肺癌诊断及分期中的应用价值。结果:胸水HPV16、HIF1α、VEGF联合检测诊断小细胞肺癌的灵敏度及特异度均高于3项指标单独检测,差异有统计学意义(P<0.05);胸水HPV16、HIF1α及VEGF联合检测在小细胞肺癌Ⅰ~Ⅱ期、Ⅲ~Ⅳ期中阳性表达率及总表达率均高于3项指标单独检测,差异有统计学意义(P<0.05)。结论:胸水HPV16、HIF1α、及VEGF联合检测在小细胞肺癌诊断中灵敏度及特异度高,可为小细胞肺癌早期诊断提供依据。
Objective: To investigate the expression of human papillomavirus type 16( HPV16),hypoxia inducible factor 1α( HIF1α) and vascular endothelial growth factor( VEGF) in pleural effusions of small cell lung cancer and its differential diagnostic value. Methods: 79 cases with small cell lung cancer combined with pleural effusion treated in our hospital from February 2013 to May 2017 were selected as the observation group,while 68 patients with benign pleural effusion were selected as the control group. The levels of HPV16,HIF1α and VEGF in the two groups were detected by the enzymelinked immunosorbent assay( ELISA) to access the clinical value of the three indexes in the differential diagnosis of small cell lung cancer. Results: The specificity of combined detection of HPV16,HIF1α and VEGF was higher than that of HPV16,HIF1α and VEGF,respectively( P < 0. 05). The positive rates of HPV16,HIF1α and VEGF in Stages Ⅰ ~ Ⅱ and Ⅲ ~ Ⅳ of SCLC were higher than those in the three separate tests( P < 0. 05). Conclusions: HPV16,HIF1αand VEGF are all expressed in pleural effusions of small cell lung cancer. The joint detection of the three indicators has high sensitivity and specificities in the diagnosis of small cell lung cancer. It provides a scientific and comprehensive theoretical basis for the early diagnosis of small cell lung cancer for further improvement of the quality of prognosis rehabilitation.

关键词(KeyWords)： 肺肿瘤;癌,小细胞;乳头瘤病毒;缺氧诱导因子;血管内皮生长因子;鉴别诊断
lung neoplasm;cancer,small cell;papillomavirus;hypoxia-inducible factor;vascular endothelial growth factor;differential diagnosis

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 史玉卿;
SHI Yuqing;Department of Pathology,Langfang People 's Hospital;

Email:

DOI: 10.19367/j.cnki.1000-2707.2018.04.022

参考文献(References)：

• [1]李艳萍,殷俊.影像学联合多项肿瘤标志物对肺癌误诊率的影响[J].湖南师范大学学报:医学版,2016,13(3):16-19.
• [2]丁珂,滕毅.血清CEA、NSE与CYFRA21-1联合检测在肺癌诊断及疗效评估中的价值[J].贵州医科大学学报,2017,42(7):803-807.
• [3]KOH,Y,JANG B,HAN S W,et al.Expression of classⅢbeta-tubulincorrelates with unfavorable survival outcome in patrents with resectdnon-small cell lung callcer[J].Thorac Oncol,2015,5(3):320-325.
• [4]喻雄杰,李艳丽,雷金华,等.多西环素对小细胞肺癌H446细胞增殖及HIF表达的影响[J].实用肿瘤杂志,2016,31(3):237-242.
• [5]石国一,刘玉玲,王敏.VEGF、HIF-1α、COX-2在非小细胞肺癌中的表达及意义[J].河北医科大学学报,2016,37(3):256-259.
• [6]KHODADAD K,KHOSRAVI A,ESFAHANI-MONFARED Z,et al.Comparing docetaxel plus cisolatin with paclitaxel plus carboplatin in chemotherapy-na6ve patients with advanced non-small-cell lung cancer:a single institute study[J].Iran J Pharm Res,2014,13(2):575-581.
• [7]袁明,王琼,吴丹,等.小细胞肺癌患者癌组织中CD44v6及血清血管内皮生长因子的表达及临床意义[J].中国综合临床,2017,33(7):625-627.
• [8]孔倩,王心悦,蒋日成,等.不同二线方案治疗178例晚期非小细胞肺癌的预后及影响因素[J].中华肿瘤杂志,2016,38(4):294-299.
• [9]金军,谢玲.紫杉醇新辅助化疗对非小细胞肺癌患者的疗效及组织IF-ITM3、MMP-9表达的影响[J].医学临床研究,2016,33(7):1322-1324.
• [10]刘佳,任宏,吕卫东,等.STMN 1m RNA在非小细胞肺癌中的表达与紫杉醇类药物化疗效果和患者生存率的关系[J].现代肿瘤医学,2016,24(19):3066-3069.
• [11]唐曦,徐炎华,汪春林,等.洛铂胸腔灌注治疗晚期非小细胞肺癌患者恶性胸腔积液的临床观察[J].肿瘤研究与临床,2016,28(11):764-766.
• [12]李爱科,李青山,林萍萍,等.HIF-1α、VEGF及MMP-9在非小细胞肺癌组织中的表达及其意义[J].医学临床研究,2017,34(9):1687-1690.

文章评论(Comment)：